17,943
Views
211
CrossRef citations to date
0
Altmetric
Review Article

Antibiotics in the environment

Pages 108-112 | Received 02 Jan 2014, Accepted 17 Feb 2014, Published online: 19 Mar 2014

References

  • Sarmah AK, Meyer MT, Boxall ABA. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere. 2006;65:725–59.
  • Kümmerer K. Antibiotics in the aquatic environment – a review – part I. Chemosphere. 2009;75:417–34.
  • Kümmerer K. Antibiotics in the aquatic environment – a review – part II. Chemosphere. 2009;75:435–41.
  • Larsson DGJ, Lööf L. Pharmaceuticals in the environment. In Läkemedelsboken. The Swedish Medical Products Agency, Uppsala, Sweden; 2014. p 1267–79. Available at www.lakemedelsboken.se; accessed 8 March 2014; Swedish
  • Larsson DGJ, de Pedro C, Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater. 2007;148:751–5.
  • Li D, Yang M, Hu J, Ren L, Zhang Y, Li K. Determination and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ Toxicol Chem. 2008;27:80–6.
  • Sim WJ, Lee JW, Lee ES, Shinb SK, Hwang SR, Oh JE. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. Chemosphere. 2011;82:179–86.
  • Kristiansson E, Fick J, Janzon A, Grabic R, Rutgersson C, Weidegård B, et al. Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements. PLoS ONE. 2011;6:e17038.
  • Fick J, Söderström H, Lindberg RH, Chau DNP, Tysklind M, Larsson DGJ. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem. 2009;28:2522–7.
  • Thomas KV, Dye C, Schlabach M, Langford KH. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Monit. 2007;9:1410–18.
  • Babic S, Mutavdzic D, Asperger D, Horvat AJM, Kaštelan-Macan M. Determination of veterinary pharmaceuticals in production wastewater by HPTLC-videodensitometry. Chromatographia. 2007;65:105–10.
  • Phillips PJ, Smith SG, Kolpin DW, Zaugg SD, Buxton HT, Furlong ET, et al. Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents. Environ Sci Technol. 2010;44:4910–16.
  • Pruden A, Larsson DGJ, Amézquita A, Collignon P, Brandt KK, Graham DW, et al. Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect. 2013;121:878–85.
  • Boxall ABA, Rudd MA, Brooks BW, Caldwell DJ, Choi K, Hickmann S, et al. Pharmaceuticals and personal care products in the environment: what are the big questions? Environ Health Perspect. 2012;120:1221–9.
  • Castensson S, Ekedahl A. Pharmaceutical waste: the patient role. In Kümmerer K, editor. Green and sustainable pharmacy. Berlin, Heidelberg: Springer-Verlag; 2010. p 179–200.
  • Naturvårdsverket [Swedish Environmental Protection Agency]. 2012. From waste management to resource management: Swedish waste management plan 2012–2017. Report 6502 Available at http://www.naturvardsverket.se/Documents/publikationer6400/978-91-620-6502-7.pdf. accessed 27 December 2013; Swedish.
  • Ye Z, Weinberg HS, Meyer MT. Trace analysis of trimethoprim and sulfonamide, macrolide, quinolone, and tetracycline antibiotics in chlorinated drinking water using liquid chromatography electrospray tandem mass spectrometry. Anal Chem. 2007;79:1135–44.
  • Rutgersson C, Gunnarsson L, Kristiansson E, Larsson DGJ. Oral exposure to industrial effluent with exceptionally high levels of drugs does not indicate acute toxic effects in rats. Environ Toxicol Chem. 2013;32:577–84.
  • Lemus JÁ, Blanco G, Grande J, Arroyo B, García-Montijano M, Martínez F. Antibiotics threaten wildlife: circulating quinolone residues and disease in avian scavengers. PLoS ONE. 2008;3:e1444.
  • Martinez JL. The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc Biol Sci. 2009;276:2521–30.
  • Wellington EMH, Boxall ABA, Cross P, Feil EJ, Gaze WH, Hawkey PM, et al. The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria. Lancet Infect Dis. 2013;13:155–65.
  • Forsberg KJ, Reyes A, Wang B, Selleck EM, Sommer MOA, Dantas G. The shared antibiotic resistome of soil bacteria and human pathogens. Science. 2012;337:1107–11.
  • Finley RL, Collignon P, Larsson DGJ, McEwen SA, Li X-Z, Gaze WH, et al. The scourge of antibiotic resistance: the important role of the environment. Clin Infect Dis. 2103;57:704–10.
  • Gaze WH, Krone SM, Larsson DGJ, Li XZ, Robinson JA, Simonet P, et al. Influence of humans on evolution and mobilization of environmental antibiotic resistome. Emerg Infect Dis. 2013. 19(7). Available at http://dx.doi.org/10.3201/eid1907.120871.
  • Ashbolt NJ, Amézquita A, Backhaus T, Borriello SP, Brandt KK, Collignon P, et al. Human health risk assessment (HHRA) for environmental development and transfer of antibiotic resistance. Environ Health Perspect. 2013;121:993–1001.
  • Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7:e1002158.
  • Marathe NP, Regina VR, Walujkar SA, Charan SS, Moore ERB, Charan SS, et al. A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria. PLoS One. 2013;8:e77310.
  • Li D, Yu T, Zhang Y, Yang M, Li Z, Liu M, et al. Antibiotic resistance characteristics of environmental bacteria from an oxytetracycline production wastewater treatment plant and the receiving river. Appl Environ Microbiol. 2010;76:3444–51.
  • Knapp CW, Dolfing J, Ehlert JAI, Graham DW. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol. 2010;44:580–7.
  • SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Assessment of the antibiotic resistance effects of biocides. Brussels, Belgium: European Commission; 2009. p 1–87.
  • Pal C, Bengtsson-Palme J, Rensing C, Kristiansson E, Larsson DGJ. BacMet: antibacterial biocide and metal resistance genes database. Nucleic Acids Res. 2014;42:D737–43.